These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38302488)

  • 41. Characteristics of male triple negative breast cancer: A population-based study.
    Ghani S; Sochat M; Luo J; Tao Y; Ademuyiwa F
    Breast J; 2020 Sep; 26(9):1748-1755. PubMed ID: 32856383
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolic syndrome risk components and mortality after triple-negative breast cancer diagnosis in postmenopausal women in the Women's Health Initiative.
    Yuan Y; Pan K; Mortimer J; Chlebowski RT; Luo J; Yan JE; Yost SE; Kroenke CH; Adams-Campbell L; Nassir R; Sun Y; Shadyab AH; Vitolins MZ; Saquib N; Wild RA; Manson JE; Nelson RA
    Cancer; 2021 May; 127(10):1658-1667. PubMed ID: 33476042
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patterns and presentations of colorectal cancer at Komfo-Anokye teaching hospital Kumasi, Ghana.
    Agyemang-Yeboah F; Yorke J; Obirikorang C; Batu EN; Acheampong E; Frempong EA; Anto EO; Amankwaa B
    Pan Afr Med J; 2017; 28():121. PubMed ID: 29515739
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of epidemiological features, clinicopathological features, and treatments between premenopausal and postmenopausal female breast cancer patients in western China: a retrospective multicenter study of 15,389 female patients.
    Feng F; Wei Y; Zheng K; Li Y; Zhang L; Wang T; Zhang Y; Li H; Ren G; Li F
    Cancer Med; 2018 Jun; 7(6):2753-2763. PubMed ID: 29673111
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer.
    Kalinsky K; Barlow WE; Gralow JR; Meric-Bernstam F; Albain KS; Hayes DF; Lin NU; Perez EA; Goldstein LJ; Chia SKL; Dhesy-Thind S; Rastogi P; Alba E; Delaloge S; Martin M; Kelly CM; Ruiz-Borrego M; Gil-Gil M; Arce-Salinas CH; Brain EGC; Lee ES; Pierga JY; Bermejo B; Ramos-Vazquez M; Jung KH; Ferrero JM; Schott AF; Shak S; Sharma P; Lew DL; Miao J; Tripathy D; Pusztai L; Hortobagyi GN
    N Engl J Med; 2021 Dec; 385(25):2336-2347. PubMed ID: 34914339
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of breast cancer subtypes and body mass index.
    Petekkaya I; Sahin U; Gezgen G; Solak M; Yuce D; Dizdar O; Arslan C; Ayyildiz V; Altundag K
    Tumori; 2013; 99(2):129-33. PubMed ID: 23748802
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Letrozole vs. tamoxifen as neoadjuvant therapy for postmenopausal patients with hormone-dependent locally-advanced breast cancer].
    Novoa Vargas A; Font López KC; Amador DD
    Ginecol Obstet Mex; 2011 Sep; 79(9):553-7. PubMed ID: 21966856
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The prognostic impact of obesity on molecular subtypes of breast cancer in premenopausal women.
    Turkoz FP; Solak M; Petekkaya I; Keskin O; Kertmen N; Sarici F; Arik Z; Babacan T; Ozisik Y; Altundag K
    J BUON; 2013; 18(2):335-41. PubMed ID: 23818343
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk factors for breast cancer subtypes among Black women undergoing screening mammography.
    Friebel-Klingner TM; Ehsan S; Conant EF; Kontos D; Domchek SM; McCarthy AM
    Breast Cancer Res Treat; 2021 Oct; 189(3):827-835. PubMed ID: 34342765
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Seeking healthcare at their 'right' time; the iterative decision process for women with breast cancer.
    Agbeko AE; Arthur J; Bayuo J; Kaburi BB; Kyei I
    BMC Cancer; 2020 Oct; 20(1):1011. PubMed ID: 33076850
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular breast cancer subtypes in premenopausal and postmenopausal African-American women: age-specific prevalence and survival.
    Ihemelandu CU; Leffall LD; Dewitty RL; Naab TJ; Mezghebe HM; Makambi KH; Adams-Campbell L; Frederick WA
    J Surg Res; 2007 Nov; 143(1):109-18. PubMed ID: 17950079
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunohistochemistry defined subtypes of breast cancer in 678 Sudanese and Eritrean women; hospitals based case series.
    Sengal AT; Haj-Mukhtar NS; Elhaj AM; Bedri S; Kantelhardt EJ; Mohamedani AA
    BMC Cancer; 2017 Dec; 17(1):804. PubMed ID: 29191181
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathologic complete response rates in triple-negative, HER2-positive, and hormone receptor-positive breast cancers after anthracycline-free neoadjuvant chemotherapy with carboplatin and paclitaxel with or without trastuzumab.
    Shinde AM; Zhai J; Yu KW; Frankel P; Yim JH; Luu T; Kruper L; Vito C; Shaw S; Vora NL; Kirschenbaum M; Somlo G
    Breast; 2015 Feb; 24(1):18-23. PubMed ID: 25467313
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinicopathological factors predicting early and late distant recurrence in estrogen receptor-positive, HER2-negative breast cancer.
    Yamashita H; Ogiya A; Shien T; Horimoto Y; Masuda N; Inao T; Osako T; Takahashi M; Endo Y; Hosoda M; Ishida N; Horii R; Yamazaki K; Miyoshi Y; Yasojima H; Tomioka N;
    Breast Cancer; 2016 Nov; 23(6):830-843. PubMed ID: 26467036
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Spectrum of complaints presented at a specialist breast clinic in kumasi, ghana.
    Ohene-Yeboah M; Amaning E
    Ghana Med J; 2008 Sep; 42(3):110-3. PubMed ID: 19274109
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treating HR+/HER2- breast cancer in premenopausal Asian women: Asian Breast Cancer Cooperative Group 2019 Consensus and position on ovarian suppression.
    Yeo W; Ueno T; Lin CH; Liu Q; Lee KH; Leung R; Naito Y; Park YH; Im SA; Li H; Yap YS; Lu YS;
    Breast Cancer Res Treat; 2019 Oct; 177(3):549-559. PubMed ID: 31270763
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Characterizing breast cancer treatment pathways in Kumasi, Ghana from onset of symptoms to final outcome: outlook towards cancer control.
    Scherber S; Soliman AS; Awuah B; Osei-Bonsu E; Adjei E; Abantanga F; Merajver SD
    Breast Dis; 2014 Jan; 34(4):139-49. PubMed ID: 24934170
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathology of Senegalese breast cancers.
    Fitzpatrick MB; Rendi MH; Kiviat NB; Toure P; Dem A; Sow PS; Hawes SE; Feng Q; Allison KH
    Pan Afr Med J; 2019; 34():67. PubMed ID: 31819783
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of Metabolic Syndrome and Its Associated Risk Factors in Type 2 Diabetes: A Descriptive Cross-Sectional Study at the Komfo Anokye Teaching Hospital, Kumasi, Ghana.
    Agyemang-Yeboah F; Eghan BAJ; Annani-Akollor ME; Togbe E; Donkor S; Oppong Afranie B
    Biomed Res Int; 2019; 2019():4562904. PubMed ID: 31187045
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.